Nebula Research & Development LLC Kura Oncology, Inc. Transaction History

Nebula Research & Development LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$5.55 - $6.92 $357,753 - $446,063	64,460 Added 112.25%	121,884 $703 Million
Q1 2025 May 15, 2025	SELL	$6.6 - $9.05 $42,517 - $58,300	-6,442 Reduced 10.09%	57,424 $379 Million
Q4 2024 Feb 14, 2025	BUY	$8.51 - $19.21 $543,499 - $1.23 Million	63,866 New	63,866 $556 Million

215

81.2M

900K

228K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $749M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Nebula Research & Development LLC, based on Form 13F filings with the SEC.

Stay updated on Nebula Research & Development LLC with notifications on news.